Increasing dairy intake for the reduction of obesity and diabetes in adolescents

Dairy consumption has decreased in the last 30 years. Canada’s Food Guide no longer recommends three servings of dairy and emphasizes plant-based diets and dairy alternatives. Associated with this decrease is an increase in overweight and the risk of obesity and Type 2 Diabetes (T2D) in adolescents. Consistent with this advice, many adolescents have increased […]

Read More
Denture internship

Prime Denture Clinic operates in a modern facility in South Edmonton, staffed by a full-time Denturist and a full-time Dental Technologist. The denture industry is rapidly evolving with the integration of digital technology in fabricating dental prostheses. However, finding staff with adequate training in these emerging technologies has been challenging. Additionally, the demands of a […]

Read More
L2M QC Spring 2025 | A High-Throughput Platform for Ribomodule Selection and Optimization in Therapeutic RNA

This project aims to assess the market potential of a platform for producing ribomodules, specialized RNA fragments designed to enhance the stability, expression control, and functionality of therapeutic RNA (ARNth). The platform leverages high-throughput screening to develop tailored ribomodules that regulate gene expression and improve RNA stability through optimized circularization. While these innovations hold great […]

Read More
L2M QC Spring 2025 | Biosynthèse innovante de CBD (Cannabidiol) : Production durable à partir de microalgues génétiquement optimisées

Nous proposons une solution innovante et respectueuse de l’environnement pour produire du Cannabidiol (CBD), une molécule reconnue pour ses nombreuses applications thérapeutiques. Aujourd’hui, la production de CBD repose principalement sur la culture de la plante de cannabis et sur des procédés d’extraction chimique, des méthodes coûteuses, gourmandes en ressources naturelles et parfois polluantes. Grâce à […]

Read More
L2M QC Spring 2025 | Sparx Genomics

Leveraging large-scale genetic data for identifying novel therapeutic targets. Developing a new drug takes an average of twelve years and costs over a billion dollars. This exorbitant cost is largely due to the high failure rate in drug development. In fact, more than 90% of drugs tested in humans will never reach the market. In […]

Read More